CalciMedica, Inc. (CALC) shareholders
Close on Nov 13, 2026Market cap $8.34MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Alafi Capital Company LLC Joint filing with Christopher D. Alafi (19.90%) | 7,220,101 | 19.90% | 13D (active) amendment | Aug 19, 2026 |
| Bering Partners II GP, L.L.C. Joint filing with Bering Partners II, L.P. (9.99%), Evgeny Zaytsev (9.99%) and 1 more | 3,553,398 | 9.99% | 13D (active) amendment | Aug 19, 2026 |
| Steven Boyd Joint filing with Armistice Capital, LLC (9.99%) | 3,411,361 | 9.99% | 13G (passive) | Jun 30, 2026 |
| Fred A. Middleton Joint filing with Timothy C. Mills (17.90%), Sanderling Ventures Partners VI, L.P. (7.10%) and 1 more | 2,550,550 | 18.30% | 13D (active) | Mar 20, 2023 |
| Woodline Partners LP | 2,489,729 | 8.10% | 13G (passive) | Jun 30, 2026 |
| Jon M. Plexico Joint filing with Stonepine Capital Management, LLC (6.00%), Stonepine Capital, L.P. (6.00%) and 1 more | 2,149,522 | 6.00% | 13G (passive) | Aug 19, 2026 |
| Philip M Sawyer Joint filing with Bering Partners II GP, L.L.C. (6.90%), Bering Partners II, L.P. (6.90%) and 1 more | 2,113,513 | 6.90% | 13D (active) | Jun 25, 2026 |
| Eric W. Roberts Joint filing with A. Rachel Leheny (6.30%) | 1,965,916 | 6.40% | 13D (active) amendment | Jun 25, 2026 |
| Alafi Capital Company, LLC Joint filing with Christopher D. Alafi (11.30%) | 1,583,153 | 11.30% | 13G (passive) amendment | Jul 22, 2025 |
| CVI Investments, Inc. Joint filing with Heights Capital Management, Inc. (5.10%) | 1,556,081 | 5.10% | 13G (passive) | Jun 23, 2026 |
| Avenue Venture Opportunities Fund II, L.P. Joint filing with Avenue Capital Management II, L.P. (8.87%), Avenue Venture Opportunities Partners II, LLC (8.87%) and 2 more | 1,359,553 | 8.87% | 13G (passive) amendment | Sep 1, 2025 |
| Avenue Capital Management II, L.P. Joint filing with Avenue Venture Opportunities Fund II, L.P. (8.87%), Avenue Venture Opportunities Partners II, LLC (8.87%) and 2 more | 1,359,553 | 8.87% | 13G (passive) amendment | Sep 1, 2025 |
| Guy Levy Joint filing with Soleus Capital Management, L.P. (7.50%), Soleus GP, LLC (7.50%) | 1,075,856 | 7.50% | 13G (passive) amendment | Sep 30, 2025 |
| Philip Sawyer ("Sawyer") Joint filing with Bering Partners II, L.P. ("Bering II") (5.80%), Bering Partners II GP, L.L.C. ("Bering II GP") (5.80%) and 1 more | 663,246 | 5.80% | 13G (passive) | Jan 23, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CALC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Woodline Partners LP | 497,946 | 1.46% | $2.56M | New | 0.01% |
| Heights Capital Management, Inc | 311,216 | 0.91% | $1.60M | New | 0.37% |
| Squadron Capital Management LLC | 248,973 | 0.73% | $1.28M | New | 0.40% |
| Stempoint Capital LP | 248,973 | 0.73% | $1.20M | New | 0.21% |
| Stonepine Capital Management, LLC | 124,486 | 0.36% | $544.94K | New | 0.31% |
| L1 Global Manager Pty Ltd | 49,794 | 0.15% | $256.44K | New | 0.18% |
| Morgan Stanley | 28,649 | 0.08% | $147.54K | New | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 24,000 | 0.07% | $124.00K | +12,000 | 0.00% |
| Geode Capital Management, LLC | 22,095 | 0.06% | $113.85K | −2,581 | 0.00% |
| Renaissance Technologies LLC | 19,460 | 0.06% | $100.22K | −6,155 | 0.00% |
| Vanguard Capital Management LLC | 17,791 | 0.05% | $91.63K | −16,031 | 0.00% |
| 180 Wealth Advisors, LLC | 16,680 | 0.05% | $85.90K | −8,620 | 0.01% |
| XTX Topco Ltd | 15,658 | 0.05% | $80.64K | New | 0.00% |
| Hrt Financial LP | 9,365 | 0.03% | $48.00K | +1,425 | 0.00% |
| Vanguard Fiduciary Trust Co | 9,166 | 0.03% | $47.20K | – | 0.00% |
| Susquehanna International Group, Llp | 8,794 | 0.03% | $45.29K | +2,651 | 0.00% |
| Rockefeller Capital Management L.P. | 4,000 | 0.01% | $20.60K | +3,000 | 0.00% |
| Gsa Capital Partners Llp | 3,494 | 0.01% | $18.00K | −1,261 | 0.00% |
| State Street Corp | 3,415 | 0.01% | $17.59K | – | 0.00% |
| TritonPoint Partners, LLC | 3,024 | 0.01% | $15.57K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 31 | 2M | 4.9% | 10 / 5 | 6 / 6 | 2M | 0M |
| Q1 2026 | 27 | 0M | 0.6% | 11 / 4 | 5 / 13 | 0M | 1M |
| Q4 2025 | 31 | 1M | 2.2% | 7 / 5 | 8 / 6 | 0M | 0M |
| Q3 2025 | 31 | 1M | 2.1% | 7 / 4 | 10 / 6 | 0M | 0M |
| Q2 2025 | 30 | 1M | 2.2% | 4 / 10 | 3 / 4 | 0M | 0M |
| Q1 2025 | 30 | 1M | 2.3% | 4 / 7 | 5 / 3 | 0M | 0M |
| Q4 2024 | 29 | 1M | 2.5% | 10 / 8 | 3 / 5 | 0M | 0M |
| Q3 2024 | 24 | 1M | 1.8% | 6 / 5 | 3 / 2 | 0M | 0M |
| Q2 2024 | 21 | 1M | 1.7% | 6 / 3 | 5 / 5 | 0M | 0M |
| Q1 2024 | 20 | 1M | 2.1% | 9 / 6 | 0 / 1 | 1M | 0M |
| Q4 2023 | 12 | 0M | 0.3% | 0 / 5 | 1 / 1 | 0M | 0M |
| Q3 2023 | 13 | 0M | 0.4% | 3 / 3 | 1 / 3 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Eric W. Roberts | CHIEF BUSINESS OFFICER, Director | 1,250,466 | 3.66% | Nov 5, 2026 |
| A. Rachel Leheny | CHIEF EXECUTIVE OFFICER, Director | 1,061,481 | 3.11% | Sep 28, 2026 |
| Sudarshan Hebbar | Chief Medical Officer | 186,025 | 0.54% | Sep 28, 2026 |
| Kenneth A. Stauderman | Chief Scientific Officer | 12,944 | 0.04% | Sep 28, 2026 |
| Stephen Bardin | Chief Financial Officer | 43,000 | 0.13% | Sep 28, 2026 |
| Michael J. Dunn | President and COO | 11,761 | 0.03% | Apr 7, 2026 |
| Frederic Guerard | Director | 111,110 | 0.33% | Oct 5, 2026 |
| Allan Shaw | Director | – | – | Oct 5, 2026 |
| Alan Glicklich | Director | – | – | Oct 5, 2026 |
| Robert N. Wilson | Director | 1,604,650 | 4.70% | Oct 5, 2026 |
| Evgeny Zaytsev | Director | 2,113,513 | 6.19% | Oct 5, 2026 |
| Fred A. Middleton | Director, 10% owner | 2,700,834 | 7.91% | Jun 29, 2026 |
| Capital Co Llc Alafi | 10% owner | 5,112,345 | 14.97% | Aug 24, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Jun 25, 2026 | Award | +186,729 | $0.80 | $149.38K | 317,655 |
| Fred A. Middleton Director, 10% owner | Jun 25, 2026 | Buy | +248,972 | $0.80 | $199.18K | 1,063,272 |
| Sudarshan Hebbar Chief Medical Officer | Jun 25, 2026 | Award | +124,486 | $0.80 | $99.59K | 186,025 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 25, 2026 | Award | +186,729 | $0.80 | $149.38K | 366,435 |
| Robert N. Wilson Director | Jun 25, 2026 | Award | +1,182,621 | $0.80 | $946.10K | 1,604,650 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 18, 2025 | Buy | +2,500 | $3.07 | $7.68K | 84,150 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 15, 2025 | Buy | +3,400 | $2.68 | $9.11K | 81,650 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 12, 2025 | Buy | +5,000 | $3.12 | $15.60K | 78,250 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Sep 9, 2025 | Buy | +2,343 | $3.15 | $7.38K | 73,250 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 29, 2025 | Buy | +800 | $2.74 | $2.19K | 70,907 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 28, 2025 | Buy | +9,200 | $2.86 | $26.31K | 70,107 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 21, 2025 | Buy | +3,508 | $2.79 | $9.79K | 60,907 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 20, 2025 | Buy | +2,000 | $2.72 | $5.44K | 57,399 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 20, 2025 | Option exercise | +15,000 | $1.53 | $22.95K | 179,706 |
| Sudarshan Hebbar Chief Medical Officer | Aug 19, 2025 | Buy | +9,563 | $2.82 | $26.97K | 61,539 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 19, 2025 | Buy | +1,000 | $2.79 | $2.79K | 55,399 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 15, 2025 | Buy | +5,076 | $2.90 | $14.72K | 54,399 |
| Sudarshan Hebbar Chief Medical Officer | Aug 15, 2025 | Buy | +4,392 | $2.79 | $12.25K | 51,976 |
| Sudarshan Hebbar Chief Medical Officer | Aug 14, 2025 | Buy | +1,584 | $2.59 | $4.10K | 47,584 |
| Kenneth A. Stauderman Chief Scientific Officer | Jul 28, 2025 | Buy | +1,000 | $3.96 | $3.96K | 12,944 |
| Kenneth A. Stauderman Chief Scientific Officer | Jul 25, 2025 | Sale | −1,000 | $3.65 | $3.65K | 0 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 22, 2025 | Buy | +1,500 | $3.78 | $5.67K | 49,323 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 21, 2025 | Buy | +1,500 | $3.37 | $5.06K | 47,823 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Jul 21, 2025 | Buy | +1,000 | $3.40 | $3.40K | 3,500 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 18, 2025 | Buy | +2,000 | $2.88 | $5.76K | 46,323 |
| Robert N. Wilson Director | Jul 18, 2025 | Buy | +4,500 | $2.87 | $12.92K | 422,029 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 14, 2025 | Buy | +6,500 | $2.43 | $15.80K | 44,323 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Jul 14, 2025 | Buy | +2,500 | $2.47 | $6.18K | 2,500 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jul 9, 2025 | Buy | +5,000 | $1.60 | $8.00K | 37,823 |
| Kenneth A. Stauderman Chief Scientific Officer | Jul 1, 2025 | Buy | +1,000 | $1.85 | $1.85K | 1,000 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 26, 2025 | Buy | +4,500 | $1.44 | $6.48K | 32,823 |
| Stephen Bardin Chief Financial Officer | Jun 26, 2025 | Buy | +2,000 | $1.50 | $3.00K | 3,000 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 11, 2025 | Buy | +5,000 | $1.85 | $9.25K | 28,323 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 6, 2025 | Buy | +5,000 | $1.78 | $8.90K | 23,323 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 5, 2025 | Buy | +5,100 | $1.70 | $8.67K | 18,323 |
| Stephen Bardin Chief Financial Officer | May 30, 2025 | Buy | +1,000 | $1.69 | $1.69K | 41,000 |
| Fred A. Middleton Director, 10% owner | Dec 6, 2024 | Buy | +4,800 | $2.65 | $12.72K | 36,514 |
| Fred A. Middleton Director, 10% owner | Nov 1, 2024 | Buy | +877 | $3.75 | $3.29K | 22,479 |
| Fred A. Middleton Director, 10% owner | Nov 1, 2024 | Buy | +86,867 | $3.75 | $325.75K | 814,300 |
| Fred A. Middleton Director, 10% owner | Nov 1, 2024 | Buy | +20,000 | $3.75 | $75.00K | 31,714 |
| Venture Partners VI LP Sanderling 10% owner | Nov 1, 2024 | Buy | +86,867 | $3.75 | $325.75K | 814,300 |
| Venture Partners VI LP Sanderling 10% owner | Nov 1, 2024 | Buy | +877 | $3.75 | $3.29K | 22,479 |
| Robert N. Wilson Director | Nov 1, 2024 | Buy | +53,333 | $3.75 | $200.00K | 417,529 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Nov 1, 2024 | Buy | +20,000 | $3.75 | $75.00K | 130,926 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Nov 1, 2024 | Buy | +53,333 | $3.75 | $200.00K | 164,706 |
| Michael J. Dunn President and COO | Sep 9, 2024 | Option exercise | +11,761 | $1.39 | $16.35K | 11,761 |
| A. Rachel Leheny CHIEF EXECUTIVE OFFICER, Director, 10% owner | Aug 27, 2024 | Buy | +1,000 | $4.19 | $4.19K | 110,926 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 23, 2024 | Buy | +3,000 | $3.57 | $10.71K | 13,223 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 23, 2024 | Buy | +2,000 | $3.58 | $7.16K | 46,894 |
| Robert N. Wilson Director | Aug 23, 2024 | Buy | +54,000 | $3.72 | $200.88K | 364,196 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Aug 21, 2024 | Buy | +5,000 | $4.04 | $20.20K | 44,894 |
| Robert N. Wilson Director | Jun 28, 2024 | Buy | +51,278 | $3.52 | $180.50K | 310,196 |
| Robert N. Wilson Director | Jun 27, 2024 | Buy | +8,443 | $3.23 | $27.27K | 258,918 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Jun 27, 2024 | Buy | +5,000 | $3.22 | $16.10K | 10,223 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Apr 2, 2024 | Buy | +3,254 | $3.90 | $12.69K | 39,894 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Apr 1, 2024 | Buy | +746 | $3.90 | $2.91K | 36,640 |
| Eric W. Roberts CHIEF BUSINESS OFFICER, Director, 10% owner | Feb 5, 2024 | Award | +91,086 | $4.27 | $388.94K | 111,373 |
| Venture Partners VI LP Sanderling 10% owner | Jan 23, 2024 | Buy | +144,676 | $3.70 | $535.30K | 727,433 |
| Venture Partners VI LP Sanderling 10% owner | Jan 23, 2024 | Buy | +243,356 | $3.70 | $900.42K | 946,744 |
| Venture Partners VI LP Sanderling 10% owner | Jan 23, 2024 | Buy | +194,472 | $3.70 | $719.55K | 435,148 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CalciMedica's stock actually held short. Settlement fails (shares not delivered on time) peaked at 94,855 shares on Aug 31, 2026 over the last 90 days.
See a number that looks wrong?